Guidance to Reflect Transaction; Maintains Outlook for Remaining Businesses BATESVILLE, Ind., Feb. 5, 2025 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

(Batesville, IN) – Hillenbrand Inc. has announced plans to sell a 51 percent stake in its Cincinnati-based subsidiary Milacron LLC, to an affiliate of Boston-based investment firm Bain Capital.

Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

A delay to US tariffs on goods from Mexico and Canada has done little to suggest Trump will change his course on trade levies ...

Dallas native Jim Baldwin spent a quarter century at Keurig Dr. Pepper, most recently as chief legal officer, GC and ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

Thursday's trading session is showcasing significant movements among stocks across different market cap ranges. Notably, mega ...

Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction, ...

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

Good morning. Welcome to the WTW Fourth Quarter and Full Year 2024 Earnings Conference Call. Please refer to wtwco.com for ...